Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic.

PubWeight™: 1.39‹?› | Rank: Top 10%

🔗 View Article (PMC 2440343)

Published in J Comp Neurol on February 01, 2008

Authors

Patricia Tagliaferro1, Marisela Morales

Author Affiliations

1: Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224, USA.

Articles citing this

Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology (2010) 3.81

Single rodent mesohabenular axons release glutamate and GABA. Nat Neurosci (2014) 2.79

The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology (Berl) (2012) 1.96

Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci (2010) 1.82

Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Curr Opin Investig Drugs (2010) 1.49

A glutamatergic reward input from the dorsal raphe to ventral tegmental area dopamine neurons. Nat Commun (2014) 1.21

Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons. Nat Neurosci (2015) 1.21

Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2. J Neurosci (2011) 1.13

Synaptic effects induced by alcohol. Curr Top Behav Neurosci (2013) 1.13

Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA. Psychopharmacology (Berl) (2011) 1.12

Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. J Neurosci (2009) 1.11

Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons. J Comp Neurol (2008) 1.08

Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems. Physiol Behav (2011) 1.07

A ventral tegmental CRF-glutamate-dopamine interaction in addiction. Brain Res (2009) 1.07

Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs. Int Rev Neurobiol (2010) 1.05

The novel synaptogenic protein Farp1 links postsynaptic cytoskeletal dynamics and transsynaptic organization. J Cell Biol (2012) 1.05

Stress and VTA synapses: implications for addiction and depression. Eur J Neurosci (2014) 0.99

Alcohol in excess: CRF₁ receptors in the rat and mouse VTA and DRN. Psychopharmacology (Berl) (2012) 0.96

VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation. Nat Neurosci (2014) 0.96

Roles for gamma-aminobutyric acid in the development of the paraventricular nucleus of the hypothalamus. J Comp Neurol (2010) 0.95

Ventral tegmental glutamate: a role in stress-, cue-, and cocaine-induced reinstatement of cocaine-seeking. Neuropharmacology (2008) 0.94

Glutamatergic and dopaminergic neurons in the mouse ventral tegmental area. Eur J Neurosci (2015) 0.94

Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administration. J Neurosci (2014) 0.93

Stress-induced cocaine seeking requires a beta-2 adrenergic receptor-regulated pathway from the ventral bed nucleus of the stria terminalis that regulates CRF actions in the ventral tegmental area. J Neurosci (2014) 0.91

Glutamate neurons in the substantia nigra compacta and retrorubral field. Eur J Neurosci (2013) 0.89

Social isolation and stress related hormones modulate the stimulating effect of ethanol in preweanling rats. Behav Brain Res (2010) 0.85

Increased mesocorticolimbic dopamine during acute and repeated social defeat stress: modulation by corticotropin releasing factor receptors in the ventral tegmental area. Psychopharmacology (Berl) (2015) 0.85

Reversal of inhibition of putative dopaminergic neurons of the ventral tegmental area: interaction of GABA(B) and D2 receptors. Neuroscience (2012) 0.84

Neurobiological mechanisms that contribute to stress-related cocaine use. Neuropharmacology (2013) 0.84

Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity. Front Mol Neurosci (2012) 0.83

Prior extended daily access to cocaine elevates the reward threshold in a conditioned place preference test. Addict Biol (2013) 0.82

Central neural responses to restraint stress are altered in rats with an early life history of repeated brief maternal separation. Neuroscience (2011) 0.81

CRF-R2 and the heterosynaptic regulation of VTA glutamate during reinstatement of cocaine seeking. J Neurosci (2014) 0.81

Increased hippocampal excitability and impaired spatial memory function in mice lacking VGLUT2 selectively in neurons defined by tyrosine hydroxylase promoter activity. Brain Struct Funct (2014) 0.81

Stress-induced sensitization to cocaine: actin cytoskeleton remodeling within mesocorticolimbic nuclei. Eur J Neurosci (2012) 0.81

Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure. Neuropsychopharmacology (2016) 0.79

Glutamatergic mechanisms of comorbidity between acute stress and cocaine self-administration. Mol Psychiatry (2015) 0.78

Cigarettes and alcohol: The influence of nicotine on operant alcohol self-administration and the mesolimbic dopamine system. Biochem Pharmacol (2015) 0.77

Glutamate neurons are intermixed with midbrain dopamine neurons in nonhuman primates and humans. Sci Rep (2016) 0.77

Dopamine D2 receptor desensitization by dopamine or corticotropin releasing factor in ventral tegmental area neurons is associated with increased glutamate release. Neuropharmacology (2014) 0.77

Binge Drinking Decreases Corticotropin-Releasing Factor-Binding Protein Expression in the Medial Prefrontal Cortex of Mice. Alcohol Clin Exp Res (2016) 0.77

Antagonism of GABA-B but not GABA-A receptors in the VTA prevents stress- and intra-VTA CRF-induced reinstatement of extinguished cocaine seeking in rats. Neuropharmacology (2015) 0.76

Neurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuse. Neuroscience (2014) 0.76

CRF antagonism within the ventral tegmental area but not the extended amygdala attenuates the anxiogenic effects of cocaine in rats. Pharmacol Biochem Behav (2015) 0.75

Area-specific analysis of the distribution of hypothalamic neurons projecting to the rat ventral tegmental area, with special reference to the GABAergic and glutamatergic efferents. Front Neuroanat (2015) 0.75

Inhibitory effect of NMDA receptors in the ventral tegmental area on hormonal and eating behavior responses to stress in rats. Behav Neurol (2014) 0.75

Beyond the Classic VTA: Extended Amygdala Projections to DA-Striatal Paths in the Primate. Neuropsychopharmacology (2017) 0.75

Articles cited by this

The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol (1963) 185.56

The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev (1993) 19.60

Dopamine, learning and motivation. Nat Rev Neurosci (2004) 11.97

Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64

A psychomotor stimulant theory of addiction. Psychol Rev (1987) 6.42

CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol (2004) 5.21

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology (1983) 4.67

Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev (1992) 4.03

Brain reward circuitry: insights from unsensed incentives. Neuron (2002) 3.98

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev (1991) 2.85

Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron (2003) 2.81

The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci U S A (2002) 2.77

Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci (2005) 2.76

Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem (1989) 2.75

A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci (2002) 2.71

The role of stress in drug self-administration. Trends Pharmacol Sci (1998) 2.36

Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J Neurosci (1988) 2.32

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res (1999) 2.08

The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) (2000) 2.06

The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci (1998) 1.91

Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res (1995) 1.90

Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci (1997) 1.84

CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl) (1998) 1.58

Selective activation of mesocortical DA system by stress. Nature (1976) 1.56

The functional neuroanatomy of corticotropin-releasing factor. Ciba Found Symp (1993) 1.52

Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem (1999) 1.49

Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur J Neurosci (2006) 1.48

The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res (1990) 1.45

Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem (1993) 1.22

Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Psychopharmacology (Berl) (2006) 1.17

Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther (1987) 1.12

Corticotropin-releasing factor is preferentially colocalized with excitatory rather than inhibitory amino acids in axon terminals in the peri-locus coeruleus region. Neuroscience (2001) 1.03

GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area. J Comp Neurol (2001) 1.01

Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther (1989) 0.95

Flow cytometric analysis and isolation of permeabilized dopamine nerve terminals from rat striatum. J Neurosci (1989) 0.93

Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system. Brain Res Mol Brain Res (1996) 0.89

The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain. Brain Res (1998) 0.89

Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions. Brain Res (1987) 0.84

Articles by these authors

Glutamatergic neurons are present in the rat ventral tegmental area. Eur J Neurosci (2007) 2.53

Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci (2009) 2.11

Mesocorticolimbic glutamatergic pathway. J Neurosci (2011) 1.92

Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep (2012) 1.91

Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci (2010) 1.82

Role of projections from ventral medial prefrontal cortex to nucleus accumbens shell in context-induced reinstatement of heroin seeking. J Neurosci (2012) 1.56

Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatry (2009) 1.48

Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties. Brain Struct Funct (2012) 1.33

Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke (2003) 1.32

NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology (2006) 1.24

Neuroregenerative effects of BMP7 after stroke in rats. J Neurol Sci (2005) 1.22

Discharge profiles across the sleep-waking cycle of identified cholinergic, GABAergic, and glutamatergic neurons in the pontomesencephalic tegmentum of the rat. J Neurosci (2014) 1.21

Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction. Proc Natl Acad Sci U S A (2005) 1.18

Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Psychopharmacology (Berl) (2006) 1.17

Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. J Neurosci (2009) 1.12

Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain. J Neurosci (2003) 1.11

Identification of rat ventral tegmental area GABAergic neurons. PLoS One (2012) 1.09

Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons. J Comp Neurol (2008) 1.08

Expression of COUP-TFII nuclear receptor in restricted GABAergic neuronal populations in the adult rat hippocampus. J Neurosci (2010) 1.07

A ventral tegmental CRF-glutamate-dopamine interaction in addiction. Brain Res (2009) 1.07

Duration of inhibition of ventral tegmental area dopamine neurons encodes a level of conditioned fear. J Neurosci (2011) 1.05

Effects of cerebral ischemia in mice deficient in Persephin. Proc Natl Acad Sci U S A (2002) 0.98

Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells. J Neurovirol (2012) 0.96

(+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J Pharmacol Exp Ther (2005) 0.94

Glutamatergic and dopaminergic neurons in the mouse ventral tegmental area. Eur J Neurosci (2015) 0.94

The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J Pharmacol Exp Ther (2003) 0.90

Antipsychotic clozapine inhibits the function of alpha7-nicotinic acetylcholine receptors. Neuropharmacology (2006) 0.90

Rewarding injections of the cholinergic agonist carbachol into the ventral tegmental area induce locomotion and c-Fos expression in the retrosplenial area and supramammillary nucleus. Brain Res (2003) 0.90

Glutamate neurons in the substantia nigra compacta and retrorubral field. Eur J Neurosci (2013) 0.89

Differential effects of endogenous and synthetic cannabinoids on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes. J Pharmacol Exp Ther (2004) 0.89

Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Mol Neurodegener (2014) 0.87

Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos. Eur J Neurosci (2003) 0.87

Selective induction of c-Fos immunoreactivity in the prelimbic cortex during reinstatement of heroin seeking induced by acute food deprivation in rats. Behav Brain Res (2003) 0.86

Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. Synapse (2002) 0.86

Role of adenosine in the control of homosynaptic plasticity in striatal excitatory synapses. J Integr Neurosci (2005) 0.86

A potential role for adiponectin receptor 2 (AdipoR2) in the regulation of alcohol intake. Brain Res (2010) 0.85

Expression of serotonin receptors in allergic contact eczematous human skin. Arch Dermatol Res (2002) 0.84

Acute methamphetamine administration upregulates NGFI-B mRNA expression in the striatum: co-localization with c-Fos immunoreactivity. Synapse (2002) 0.82

Stimulation of adenosine receptors selectively activates gene expression in striatal enkephalinergic neurons. Neuropsychopharmacology (2006) 0.82

Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors. Synapse (2003) 0.81

Expression of serotonergic receptors in psoriatic skin. Arch Dermatol Res (2006) 0.81

Increased hippocampal excitability and impaired spatial memory function in mice lacking VGLUT2 selectively in neurons defined by tyrosine hydroxylase promoter activity. Brain Struct Funct (2014) 0.81

Repeated amphetamine administration outside the home cage enhances drug-induced Fos expression in rat nucleus accumbens. Behav Brain Res (2007) 0.79

Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. Eur J Pharmacol (2007) 0.78

Additive effects of endogenous cannabinoid anandamide and ethanol on alpha7-nicotinic acetylcholine receptor-mediated responses in Xenopus Oocytes. J Pharmacol Exp Ther (2005) 0.78

Hypothalamic proteoglycan syndecan-3 is a novel cocaine addiction resilience factor. Nat Commun (2013) 0.78

Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice. Synapse (2002) 0.77

Corrigendum: Circuit specificity in the inhibitory architecture of the VTA regulates cocaine-induced behavior. Nat Neurosci (2017) 0.75